Back to results
US 2012/0252792 A1Published application
Methods and compositions for modulating rho-mediated gene transcription
AssigneeThe Regents of the University of Michigan
InventorsRichard Neubig, Chris Evelyn, Jenny Ryu, Scott Larsen, Jessica Bell
Life of this patent
Estimating the term…
Abstract
The invention provides methods, compositions, and kits for the inhibition of members of the Rho GTPase family. Specifically, the invention provides methods, compositions and kits for the inhibition of RhoA and/or RhoC transcriptional signalling. The invention finds use in treatment of Rho-mediated disease states (e.g., tumor metastasis, inflammation, inflammatory disease), Rho-mediated biological conditions, and in cell signaling research.
Claims27
A composition comprising a compound selected from the group consisting of
- wherein G1 and G2 may be independently selected from the group consisting of (C═O)NH, NH(C═O), (C═O)NHO, NH, O, NH(C═O)O, O(C═O)NH, and heteroaryl;
- wherein p and q may be independently 1, 2, 3, 4, or 5;
- wherein R1 and R2 may be one or more functional groups independently selected from the group consisting of halogen, CF3, OCF3, CN, O(C1-C6 alkyl), and C1-C6 alkyl;
- wherein X, Y, Z are independently:
- (CH2)m wherein m is 0, 1, or 2 and n is 1, 2, or 3;
- wherein G1 and G2 are not CONH when R1 is 3,5-bis(CF3) and R2 is 4-Cl;
- wherein heteroaryl is selected from the group consisting of 1,3-thiazole and isoxazole;
- and
- wherein T is selected from the group consisting of:
6 more elements
Dependencies are inferred from the claim text.